|Articles|December 10, 2011
Video blog: HER2-targeted agents
Author(s)Debu Tripathy
Advertisement
Dr. Debu Tripathy explains the HER2 pathway's involvement in breast cancer and how new investigational drugs, including pertuzumab and TDM1, as well as combinations of new and approved drugs are targeting this pathway.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Top 5 Breast Cancer Stories of 2025: Research, Treatments and Care
2
Tukysa Makes Waves as Firstline Maintenance in HER2+ Breast Cancer
3
FDA Grants Breakthrough Status to Zoldonrasib in Lung Cancer
4
Breaking Down Side Effects of Tukysa in HER2+ Breast Cancer
5